DPC 963
DPC-963 is an oral active non-nucleoside reverse transcriptase inhibitor with the IC50 of 18 nM. DPC-963 can be used for study of HIV.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 214287-90-8
- Fòrmula: C14H9F5N2O
- Peso molecular:316.23
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 214287-90-8
-
Peso molecular 316.23
-
Fòrmula C14H9F5N2O
-
SMILES
FC(F)(F)[C@@]1(C2=C(F)C(F)=CC=C2NC(N1)=O)C#CC3CC3
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Corbett JW, et al. Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1999;43(12):2893-2897. [Content Brief]
[2]. Corbett JW, et al. Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. J Med Chem. 2000;43(10):2019-2030. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)